📰 Pocare Network News
Page 2 - Pocare Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pocare Network. Real-time updates on events, politics, business and more.
August 16, 2022
Secures Funding from Metalmark Capital Partners to Drive Growth Orgenesis to Host Conference Call Today, August 16, 2022 at 11 AM Eastern Time ...
August 15, 2022
GERMANTOWN, Md., Aug. 15, 2022 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will host a conference call at... | August 15, 2022
August 15, 2022
GERMANTOWN, Md., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...
May 24, 2022
GERMANTOWN, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...
May 3, 2022
Focus is to Develop Cost-effective Production of Autologous Induced Pluripotent Stem Cells (iPSCs) using Microfluidic Technologies and Artificial...
March 30, 2022
GERMANTOWN, Md., March 30, 2022 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies, today reports its financial results for the year ended... | March 30, 2022
January 28, 2022
Orgenesis (ORGS) is 0.35% higher on its value in year-to-date trading and has touched a high of $8.30 in the current 52-week trading range.
January 28, 2022
Orgenesis reaches next milestone in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid  Orgenesis achieves milestone in the placement of the Orgenesis Mobile Processing Units and Lab (OMPUL) for the development of cell and gene therapies at the Hospital OMPULs expected to cont...
January 18, 2022
Orgenesis and Johns Hopkins University expand POCare in Maryland through creation of the Maryland Center for Cell Therapy ManufacturingGermantown, Maryland, US, January 18, 2022 -Orgenesis Inc. - (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock th...
January 18, 2022
Orgenesis and The Johns Hopkins University will construct a cell and gene therapy processing facility for point of care treatment of patients at Johns Hopkins.